Express Pharma

IndiaRF to acquire API and CRAMS business of Ind-Swift for Rs 1,650 cr

Ind-Swift reported a consolidated revenue of Rs 1,207 crores and consolidated EBITDA of Rs 256 crores in FY23

0 498